Total Payments
$18,050
2024 Payments
$4,585
Companies
66
Transactions
928
Medicare Patients
2,208
Medicare Billing
$436,644
Payment Breakdown by Category
Food & Beverage$16,845 (93.3%)
Travel$1,024 (5.7%)
Education$150.17 (0.8%)
Other$31.47 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,845 | 919 | 93.3% |
| Travel and Lodging | $1,024 | 3 | 5.7% |
| Education | $150.17 | 4 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31.47 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,311 | 151 | $0 (2024) |
| LivaNova USA, Inc. | $1,868 | 25 | $0 (2024) |
| Allergan, Inc. | $1,425 | 114 | $0 (2022) |
| Biogen, Inc. | $1,054 | 73 | $0 (2024) |
| UCB, Inc. | $1,026 | 54 | $0 (2024) |
| GENZYME CORPORATION | $728.47 | 40 | $0 (2023) |
| EMD Serono, Inc. | $523.86 | 25 | $0 (2024) |
| PFIZER INC. | $514.24 | 34 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $469.96 | 21 | $0 (2024) |
| SK Life Science, Inc. | $466.78 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,585 | 145 | LivaNova USA, Inc. ($1,516) |
| 2023 | $2,771 | 132 | AbbVie Inc. ($981.93) |
| 2022 | $2,371 | 133 | ABBVIE INC. ($683.39) |
| 2021 | $2,643 | 163 | UCB, Inc. ($426.57) |
| 2020 | $1,074 | 59 | Allergan, Inc. ($285.46) |
| 2019 | $1,586 | 97 | Allergan Inc. ($234.74) |
| 2018 | $1,826 | 116 | Allergan Inc. ($308.01) |
| 2017 | $1,194 | 83 | Allergan Inc. ($277.30) |
All Payment Transactions
928 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Central Nervous System | ||||||
| 12/19/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Musculoskeletal | ||||||
| 12/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Neurology | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.65 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $2.39 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $0.74 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Central Nervous System | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Neurology | ||||||
| 10/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Neurology | ||||||
| 10/21/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Musculoskeletal | ||||||
| 10/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $21.90 | General |
| 10/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Rare Disease | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: PAIN | ||||||
| 10/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.18 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Pain Management | ||||||
| 10/07/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $9.15 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 527 | 9,042 | $330,401 | $114,725 |
| 2022 | 9 | 561 | 8,897 | $315,805 | $110,876 |
| 2021 | 9 | 492 | 9,643 | $312,407 | $111,335 |
| 2020 | 11 | 628 | 7,406 | $300,606 | $99,708 |
Total Patients
2,208
Total Services
34,988
Medicare Billing
$436,644
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 21 | 8,355 | $95,730 | $41,463 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 236 | 369 | $116,907 | $36,665 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 126 | 126 | $59,516 | $17,290 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 90 | $19,749 | $6,563 | 33.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 21 | 47 | $19,841 | $5,910 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 40 | $16,939 | $5,563 | 32.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 14 | 15 | $1,719 | $1,271 | 73.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 17 | 8,200 | $93,954 | $39,994 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 180 | 261 | $82,690 | $27,648 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 124 | 124 | $58,571 | $15,856 | 27.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 78 | 103 | $11,802 | $8,538 | 72.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 45 | $19,057 | $6,694 | 35.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 20 | 48 | $20,263 | $5,592 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 55 | $12,069 | $3,805 | 31.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 46 | 48 | $3,763 | $2,097 | 55.7% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2022 | 11 | 13 | $13,637 | $652.42 | 4.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 19 | 9,000 | $103,121 | $43,681 | 42.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 277 | $87,759 | $27,347 | 31.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 108 | 108 | $51,014 | $14,596 | 28.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 54 | 68 | $28,797 | $10,613 | 36.9% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 19 | 46 | $19,419 | $5,752 | 29.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 70 | $15,360 | $4,953 | 32.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 43 | 50 | $3,920 | $2,853 | 72.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 11 | $1,260 | $926.40 | 73.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 13 | $1,757 | $613.60 | 34.9% |
About Dr. Ruby Ali, M.D
Dr. Ruby Ali, M.D is a Neurology healthcare provider based in Fairfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1093990426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ruby Ali, M.D has received a total of $18,050 in payments from pharmaceutical and medical device companies, with $4,585 received in 2024. These payments were reported across 928 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($16,845).
As a Medicare-enrolled provider, Ali has provided services to 2,208 Medicare beneficiaries, totaling 34,988 services with total Medicare billing of $436,644. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Fairfield, CA
- Active Since 01/03/2008
- Last Updated 01/31/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1093990426
Products in Payments
- QULIPTA (Drug) $2,516
- VNS Therapy (Device) $1,782
- BOTOX (Biological) $1,134
- NURTEC ODT (Drug) $1,033
- Vimpat (Drug) $896.47
- TYSABRI (Biological) $715.67
- UBRELVY (Drug) $629.57
- AUBAGIO (Drug) $518.23
- NUPLAZID (Drug) $375.98
- ZEPOSIA (Drug) $353.83
- TECFIDERA (Drug) $325.46
- BOTOX COSMETIC (Biological) $268.87
- RYTARY (Drug) $265.22
- TROKENDI XR (Drug) $234.20
- Rebif (Biological) $219.52
- STELARA (Biological) $219.06
- AIMOVIG (Biological) $212.44
- AUSTEDO (Drug) $202.90
- LEMTRADA (Drug) $186.72
- EMGALITY (Drug) $173.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fairfield
Peter Mcallister, M.d, M.D
Neurology — Payments: $2.3M
Neurology $2.3M
P. Christopher Gottschalk, M.d, M.D
Neurology — Payments: $400,249
Neurology $400,249
Jeffrey Gross, M.d, M.D
Neurology — Payments: $191,862
Neurology $191,862
Dr. Nicholas Blondin, M.d, M.D
Neurology — Payments: $144,704
Neurology $144,704
Srinath Kadimi, M.d, M.D
Neurology — Payments: $44,527
Neurology $44,527
Dario Zagar, M.d, M.D
Neurology — Payments: $19,926
Neurology $19,926